✦ LIBER ✦

Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

✍ Scribed by Konings, I R H M; de Jonge, M J A; Burger, H; van der Gaast, A; van Beijsterveldt, L E C; Winkler, H; Verweij, J; Yuan, Z; Hellemans, P; Eskens, F A L M

Book ID: 110000653
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 302 KB
Volume: 103
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605867

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacological study of t

A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours

✍ Wall, L; Talbot, D C; Bradbury, P; Jodrell, D I 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

Phase I and pharmacological study of the

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

✍ Siegel-Lakhai, W S; Crul, M; Zhang, S; Sparidans, R W; Pluim, D; Howes, A; Solan 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Phase I study of the multidrug resistanc

Phase I study of the multidrug resistance inhibitor zosuquidar administered in combination with vinorelbine in patients with advanced solid tumours

✍ Lyly H. Lê; Malcolm J. Moore; Lillian L. Siu; Amit M. Oza; Martha MacLean; Bryn 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 285 KB

A phase I and pharmacologic study of the

A phase I and pharmacologic study of the matrix metalloproteinase inhibitor CP-471,358 in patients with advanced solid tumors

✍ André Planting; Ate van der Gaast; Patrick Schöffski; Michele Bartkowski; Coleta 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 219 KB

Phase I clinical, pharmacokinetic and ph

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

✍ Razak, A R A; Hotte, S J; Siu, L L; Chen, E X; Hirte, H W; Powers, J; Walsh, W; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 308 KB

Ocular findings in patients with solid t

Ocular findings in patients with solid tumours treated with the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Phase I and II clinical trials

✍ Murray, P I; Bristow, E; Forsythe, B J; Faulkner, K; Tullo, A B; Esmaeli, B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 187 KB